Growth Metrics

Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -10.21%
Dec 31, 2025 14.79%
Sep 30, 2025 50.72%
Jun 30, 2025 -15.95%
Mar 31, 2025 1,659.83%
Dec 31, 2024 -104.70%
Sep 30, 2024 2.51%
Jun 30, 2024 40.68%
Mar 31, 2024 -58.83%
Dec 31, 2023 157.80%
Sep 30, 2023 -22.44%
Jun 30, 2023 -9.80%
Mar 31, 2022 -101.37%
Dec 31, 2021 -75.90%
Sep 30, 2021 -621.74%
Jun 30, 2021 -148.94%
Mar 31, 2021 -98.83%
Dec 31, 2020 63.06%
Sep 30, 2020 218.20%
Jun 30, 2020 59.10%
Mar 31, 2020 -209.18%
Dec 31, 2019 3.99%
Sep 30, 2019 239.95%
Jun 30, 2019 -46.43%
Mar 31, 2019 127.69%
Dec 31, 2018 -648.49%
Sep 30, 2018 -12.33%
Jun 30, 2018 4.94%
Mar 31, 2018 132.34%
Dec 31, 2017 -651.42%
Sep 30, 2017 -46.33%
Jun 30, 2017 -38.49%
Mar 31, 2017 329.41%
Dec 31, 2016 -55.86%
Sep 30, 2016 598.11%
Jun 30, 2016 -129.16%
Mar 31, 2016 391.42%
Dec 31, 2015 -268.02%
Sep 30, 2015 112.77%
Jun 30, 2015 -201.58%
Mar 31, 2015 170.73%
Dec 31, 2014 -63.45%
Sep 30, 2014 -1.82%
Jun 30, 2014 -20.35%
Mar 31, 2014 71.93%
Dec 31, 2013 -16.55%
Sep 30, 2013 1.58%
Jun 30, 2013 -30.41%
Mar 31, 2013 43.14%
Dec 31, 2012 -14.29%
Sep 30, 2012 -14.49%
Jun 30, 2012 2.87%
Mar 31, 2012 156.60%
Dec 31, 2011 -295.03%
Sep 30, 2011 -10.21%
Jun 30, 2011 -2.44%
Mar 31, 2011 498.57%
Dec 31, 2010 -81.74%
Sep 30, 2010 15.47%
Jun 30, 2010 -19.43%
Mar 31, 2010 32.35%
Dec 31, 2009 3.54%
Sep 30, 2009 -28.65%
Jun 30, 2009 3.91%